Blaine M. Hackman Ph.D.


Blaine M. Hackman Ph.D.


New York | Three Bryant Park, 1095 Avenue of the Americas, New York, NY, United States of America 10036-6797
+1 212 698 3652 | +1 212 698 3599


Blaine M. Hackman Ph.D. currently focuses his practice on patent counseling, prosecution, and post-grant proceedings, including Inter Partes Reviews (IPRs) and Post-Grant Reviews (PGRs) before the Patent Trial and Appeal Board (PTAB), in the areas of pharmaceuticals and biotechnology.  Dr. Hackman has represented pharmaceutical and biotechnology clients in intellectual property litigation (including Hatch-Waxman proceedings) and post-grant proceedings on behalf of petitioners and patent owners.  He has also prosecuted patents and counseled clients in transactions in a variety of technologies, including small molecule and protein therapies, nanotechnology, diagnostic imaging, and analytical chemistry.

Dr. Hackman has published and presented on intellectual property-related issues and he was recognized for authoring an Article of the Month by the Licensing Executive Society International Journal, les Nouvelles. He has also been recognized as a Rising Star by Super Lawyers in their intellectual property category in 2017-2019.

  • Advise Royalty Pharma in its US$650 million royalty purchase agreement with PTC Therapeutics, Inc. to acquire a portion of PTC’s royalty interest in Risdiplam.
  • Represent a major pharmaceutical company in a litigation reissue patent application in the USPTO related to its blockbuster cancer treatment.
  • Represent a major pharmaceutical and biotechnology company in a district court litigation relating to a monoclonal antibody therapy. 
  • Advised Cerberus and PaxVax on patent issues related to the sale of PaxVax to Emergent BioSolutions. 
  • Helped secure four denials of institution for IPR petitions challenging four patents relating to Chiesi USA’s short-term hypertension treatment, Ready-to-Use Cardene® I.V. 
  • Secured allowance of several patents for anti-infective therapeutics on behalf of a major university and its medical center.

Includes matters handled at Dechert or prior to joining the firm.

  • Harvey Mudd College, B.S., 2001, High Honors, Dow Chemical Foundation Scholar
  • Columbia University, Ph.D., 2006
  • Georgetown University Law Center, J.D., 2013
  • New York
  • United States Patent and Trademark Office
  • Licensing Executive Society
  • American Chemical Society